TAT peptide and its conjugates: Proteolytic stability

Bioconjugate Chemistry

Volumn 20, Issue 8, 2009, Pages 1531-1537

  Grunwald, Jacob ^a,b   Rejtar, Tomas ^a   Sawant, Rupa ^a   Wang, Zhouxi ^a   Torchilin, Vladimir P ^a  

^a NORTHEASTERN UNIVERSITY   (United States)

^b ISRAEL INSTITUTE FOR BIOLOGICAL RESEARCH   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

MICROWAVE INTEGRATED CIRCUITS; PLASMA (HUMAN); PROTEOLYSIS;

CLEAVAGE KINETICS; FLUORENYLMETHYL CHLOROFORMATE; FLUORESCENT DETECTION; HALF LIVES; HUMAN BLOOD PLASMAS; LABELINGS; MALDI-TOF-MS ANALYSIS; MIXED MICELLES; PROTEOLYTIC CLEAVAGE; PROTEOLYTIC STABILITY;

DRUG DELIVERY;

CELL PENETRATING PEPTIDE; FLUORENYLMETHYL CHLOROFORMATE; FLUORESCENT DYE; MACROGOL; PHOSPHATE BUFFERED SALINE; TRANSACTIVATOR PROTEIN; TRYPSIN; UNCLASSIFIED DRUG;

ARTICLE; CARBOXY TERMINAL SEQUENCE; CONJUGATE; FRAGMENTATION REACTION; HALF LIFE TIME; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; IN VITRO GENE TRANSFER; KINETICS; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MICELLE; PLASMA; PROTEIN DEGRADATION; PROTEIN STABILITY;

CELL-PENETRATING PEPTIDES; HUMANS; KINETICS; MICELLES; PEPTIDE FRAGMENTS; PHOSPHATIDYLETHANOLAMINES; POLYETHYLENE GLYCOLS; PROTEIN STABILITY; TAT GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; TRYPSIN;

EID: 70349087365     PISSN: 10431802     EISSN: None     Source Type: Journal    
DOI: 10.1021/bc900081e     Document Type: Article

References (36)

1. Frankel, A. D., and Pabo, C. O. (1988) Cellular uptake of the tat protein from human immunodeficiency virus. Cell 55, 1189-1193. (Pubitemid 19020071)
2. Fawell, S., Seery, J., Daikh, Y., Moore, C., Chen, L. L., Pepinsky, B., and Barsoum, J. (1994) Tat-mediated delivery of heterologous proteins into cells. Proc. Natl. Acad. Sci. U.S.A. 91, 664-668. (Pubitemid 24041462)
3. Schwarze, S. R., Ho, A., Vocero-Akbani, A., and Dowdy, S. F. (1999) In vivo protein transduction: delivery of a biologically active protein into the mouse. Science 285, 1569-1572. (Pubitemid 29420581)
4. Ryser, H. J., and Hancock, R. (1965) Histones and basic polyamino acids stimulate the uptake of albumin by tumor cells in culture. Science 150, 501-503.
5. Goun, E. A., Pillow, T. H., Jones, L. R., Rothbard, J. B., and Wender, P. A. (2006) Molecular transporters: synthesis of oligoguanidinium transporters and their application to drug delivery and real-time imaging. ChemBioChem 7, 1497-1515.
6. Chauhan, A., Tikoo, A., Kapur, A. K., and Singh, M. (2007) The taming of the cell penetrating domain of the HIV Tat: myths and realities. J. Controlled Release 117, 148-162. (Pubitemid 46172502)
7. Fischer, R., Kohler, K., Fotin-Mleczek, M., and Brock, R. (2004) A stepwise dissection of the intracellular fate of cationic cell-penetrating peptides. J. Biol. Chem. 279, 12625-12635. (Pubitemid 38445834)
8. Dathe, M., Schumann, M., Wieprecht, T., Winkler, A., Beyermann, M., Krause, E., Matsuzaki, K., Murase, O., and Bienert, M. (1996) Peptide helicity and membrane surface charge modulate the balance of electrostatic and hydrophobic interactions with lipid bilayers and biological membranes. Biochemistry 35, 12612-12622. (Pubitemid 26318059)
9. Ryser, H. J. (1968) Uptake of protein by mammalian cells: an underdeveloped area. The penetration of foreign proteins into mammalian cells can be measured and their functions explored. Science 159, 390-396.
10. Fuchs, S. M., and Raines, R. T. (2004) Pathway for polyarginine entry into mammalian cells. Biochemistry 43, 2438-2444. (Pubitemid 38327839)
11. Ignatovich, I. A., Dizhe, E. B., Pavlotskaya, A. V., Akifiev, B. N., Burov, S. V., Orlov, S. V., and Perevozchikov, A. P. (2003) Complexes of plasmid DNA with basic domain 47-57 of the HIV-1 Tat protein are transferred to mammalian cells by endocytosis-mediated pathways. J. Biol. Chem. 278, 42625-42636.
12. Rothbard, J. B., Jessop, T. C., Lewis, R. S., Murray, B. A., and Wender, P. A. (2004) Role of membrane potential and hydrogen bonding in the mechanism of translocation of guanidinium-rich peptides into cells. J. Am. Chem. Soc. 126, 9506-9507.
13. Wadia, J. S., Stan, R. V., and Dowdy, S. F. (2004) Transducible TAT-HA fusogenic peptide enhances escape of TAT-fusion proteins after lipid raft macropinocytosis. Nat. Med. 10, 310-315.
14. Silhol, M., Tyagi, M., Giacca, M., Lebleu, B., and Vives, E. (2002) Different mechanisms for cellular internalization of the HIV-1 Tat-derived cell penetrating peptide and recombinant proteins fused to Tat. Eur. J. Biochem. 269, 494-501. (Pubitemid 34128006)
15. Stein, S., Weiss, A., Adermann, K., Lazarovici, P., Hochman, J., and Wellhoner, H. (1999) A disulfide conjugate between antitetanus antibodies and HIV (37-72)Tat neutralizes tetanus toxin inside chromaffin cells. FEBS Lett. 458, 383-386. (Pubitemid 29433840)
16. De Coupade, C., Fittipaldi, A., Chagnas, V., Michel, M., Carlier, S., Tasciotti, E., Darmon, A., Ravel, D., Kearsey, J., Giacca, M., and Cailler, F. (2005) Novel human-derived cell-penetrating peptides for specific subcellular delivery of therapeutic biomolecules. Biochem. J. 390, 407-418. (Pubitemid 41337102)
17. Lee, H. J., and Pardridge, W. M. (2001) Pharmacokinetics and delivery of tat and tat-protein conjugates to tissues in vivo. Bioconjugate Chem. 12, 995-999.
18. Torchilin, V. P., Levchenko, T. S., Rammohan, R., Volodina, N., Papahadjopoulos-Sternberg, B., and D'Souza, G. G. (2003) Cell transfection in vitro and in vivo with nontoxic TAT peptide-liposome-DNA complexes. Proc. Natl. Acad. Sci. U.S.A. 100, 1972-1977. (Pubitemid 36254558)
19. Ziegler, A., and Seelig, J. (2007) High affinity of the cell-penetrating peptide HIV-1 Tat-PTD for DNA. Biochemistry 46, 8138-8145. (Pubitemid 47051649)
20. Torchilin, V. P., Rammohan, R., Weissig, V., and Levchenko, T. S. (2001) TAT peptide on the surface of liposomes affords their efficient intracellular delivery even at low temperature and in the presence of metabolic inhibitors. Proc. Natl. Acad. Sci. U.S.A. 98, 8786-8791. (Pubitemid 32678105)
21. Gupta, B., Levchenko, T. S., and Torchilin, V. P. (2007) TAT peptide-modified liposomes provide enhanced gene delivery to intracranial human brain tumor xenografts in nude mice. Oncol. Res. 16, 351-359. (Pubitemid 47413251)
22. Kale, A. A., and Torchilin, V. P. (2007) "Smart" drug carriers: PEGylated TATp-modified pH-sensitive liposomes. J. Liposome Res. 17, 197-203.
23. Koch, A. M., Reynolds, F., Kircher, M. F., Merkle, H. P., Weissleder, R., and Josephson, L. (2003) Uptake and metabolism of a dual fluorochrome Tat-nanoparticle in HeLa cells. Bioconjugate Chem. 14, 1115-1121. (Pubitemid 37449038)
24. Ruan, G., Agrawal, A., Marcus, A. I., and Nie, S. (2007) Imaging and tracking of tat peptide-conjugated quantum dots in living cells: new insights into nanoparticle uptake, intracellular transport, and vesicle shedding. J. Am. Chem. Soc. 129, 14759-14766. (Pubitemid 350207890)
25. Endres, P. J., Macrenaris, K. W., Vogt, S., Allen, M. J., and Meade, T. J. (2006) Quantitative imaging of cell-permeable magnetic resonance contrast agents using x-ray fluorescence. Mol. Imaging 5, 485-497. (Pubitemid 46142822)
26. Vives, E., Brodin, P., and Lebleu, B. (1997) A truncated HIV-1 Tat protein basic domain rapidly translocates through the plasma membrane and accumulates in the cell nucleus. J. Biol. Chem. 272, 16010-16017. (Pubitemid 27265584)
27. Siomi, H., Shida, H., Maki, M., and Hatanaka, M. (1990) Effects of a highly basic region of human immunodeficiency virus Tat protein on nucleolar localization. J. Virol. 64, 1803-1807. (Pubitemid 20104919)
28. Tikhonov, I., Ruckwardt, T. J., Berg, S., Hatfield, G. S., and David Pauza, C. (2004) Furin cleavage of the HIV-1 Tat protein. FEBS Lett. 565, 89-92.
29. Trehin, R., Nielsen, H. M., Jahnke, H. G., Krauss, U., Beck-Sickinger, A. G., and Merkle, H. P. (2004) Metabolic cleavage of cell-penetrating peptides in contact with epithelial models: human calcitonin (hCT)-derived peptides, Tat(47-57) and penetratin(43-58). Biochem. J. 382, 945-956. (Pubitemid 39312909)
30. Elmquist, A., and Langel, U. (2003) In vitro uptake and stability study of pVEC and its all-D analog. Biol. Chem. 384, 387-393. (Pubitemid 36527645)
31. Schorderet, D. F., Manzi, V., Canola, K., Bonny, C., Arsenijevic, Y., Munier, F. L., and Maurer, F. (2005) D-TAT transporter as an ocular peptide delivery system. Clin. Experiment. Ophthalmol. 33, 628-635. (Pubitemid 43918404)
32. Achilefu, S., Srinivasan, A., Schmidt, M. A., Jimenez, H. N., Bugaj, J. E., and Erion, J. L. (2003) Novel bioactive and stable neurotensin peptide analogues capable of delivering radiopharmaceuticals and molecular beacons to tumors. J. Med. Chem. 46, 3403-3411. (Pubitemid 36842424)
33. Meng, H., and Kumar, K. (2007) Antimicrobial activity and protease stability of peptides containing fluorinated amino acids. J. Am. Chem. Soc. 129, 15615-15622.
34. Kale, A. A., and Torchilin, V. P. (2007) Enhanced transfection of tumor cells in vivo using "Smart" pH-sensitive TAT-modified pegylated liposomes. J. Drug Targeting 15, 538-545.
35. Lewis, J. R., Morley, J. S., and Venn, R. F. (1993) Analysis of human beta-endorphin 28-31 (melanotropin potentiating factor) and analogues by high-performance liquid chromatography of their 9-fluorenylmethoxycarbonyl derivatives. J. Chromatogr. 615, 37-45.
36. Sawant, R. M., Hurley, J. P., Salmaso, S., Kale, A., Tolcheva, E., Levchenko, T. S., and Torchilin, V. P. (2006) "SMART" drug delivery systems: double-targeted pH-responsive pharmaceutical nanocarriers. Bioconjugate Chem. 17, 943-949. (Pubitemid 44162612)